Correlation Between NLS Pharmaceutics and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both NLS Pharmaceutics and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NLS Pharmaceutics and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NLS Pharmaceutics AG and Eliem Therapeutics, you can compare the effects of market volatilities on NLS Pharmaceutics and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NLS Pharmaceutics with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NLS Pharmaceutics and Eliem Therapeutics.
Diversification Opportunities for NLS Pharmaceutics and Eliem Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between NLS and Eliem is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding NLS Pharmaceutics AG and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and NLS Pharmaceutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NLS Pharmaceutics AG are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of NLS Pharmaceutics i.e., NLS Pharmaceutics and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between NLS Pharmaceutics and Eliem Therapeutics
Assuming the 90 days horizon NLS Pharmaceutics AG is expected to generate 4.81 times more return on investment than Eliem Therapeutics. However, NLS Pharmaceutics is 4.81 times more volatile than Eliem Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.26 per unit of risk. If you would invest 1.50 in NLS Pharmaceutics AG on August 29, 2024 and sell it today you would lose (0.60) from holding NLS Pharmaceutics AG or give up 40.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NLS Pharmaceutics AG vs. Eliem Therapeutics
Performance |
| Timeline |
| NLS Pharmaceutics |
| Eliem Therapeutics |
NLS Pharmaceutics and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NLS Pharmaceutics and Eliem Therapeutics
The main advantage of trading using opposite NLS Pharmaceutics and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NLS Pharmaceutics position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| NLS Pharmaceutics vs. Reviva Pharmaceuticals Holdings | NLS Pharmaceutics vs. GeoVax Labs | NLS Pharmaceutics vs. NLS Pharmaceutics AG | NLS Pharmaceutics vs. Lixte Biotechnology Holdings |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |